Apart from a possible stratification of AML glyco-subtypes and their treatment, sLex may have also direct implications on the outcome of disease: in a recent report, both ST3GAL4 and FUT7 could be directly linked to enhanced levels of sLex on the cell surface of primary AML blasts as determined by flow cytometry [29]. This evidence concerns the gene FUT7 and acute myeloid leukemia.